Health In Tech, Inc. (HIT)
NASDAQ: HIT · Real-Time Price · USD
1.580
-0.070 (-4.24%)
Apr 23, 2026, 11:59 AM EDT - Market open
Health In Tech Stock Forecast
Stock Price Forecast
The 2 analysts that cover Health In Tech stock have a consensus rating of "Strong Buy" and an average price target of $3.25, which forecasts a 105.70% increase in the stock price over the next year. The lowest target is $2.50 and the highest is $4.00.
Price Target: $3.25 (+105.70%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Health In Tech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|
| Strong Buy | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +153.16% | Apr 20, 2026 |
| Maxim Group | Maxim Group | Strong Buy Initiates $2.5 | Strong Buy | Initiates | $2.5 | +58.23% | Jun 26, 2025 |
Financial Forecast
Revenue This Year
46.99M
from 33.33M
Increased by 41.00%
Revenue Next Year
79.71M
from 46.99M
Increased by 69.63%
EPS This Year
-0.01
from 0.02
EPS Next Year
0.17
from -0.01
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 49.0M | 84.1M |
| Avg | 47.0M | 79.7M |
| Low | 45.5M | 76.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 47.0% | 79.0% |
| Avg | 41.0% | 69.6% |
| Low | 36.4% | 62.1% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | - | 0.18 |
| Avg | -0.01 | 0.17 |
| Low | -0.01 | 0.17 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.